loadpatents
name:-0.018182992935181
name:-1.0461978912354
name:-0.0073819160461426
Pastan; Ira Patent Filings

Pastan; Ira

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pastan; Ira.The latest application filed is for "blocking mesothelin peptide fragments".

Company Profile
  • Pastan; Ira - Potomac MD US
  • Pastan; Ira - Bethesda MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
Grant 9,592,304 - FitzGerald , et al. March 14, 2
2017-03-14
Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
App 20150218286 - WAYNE; Alan S. ;   et al.
2015-08-06
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
Grant 8,809,502 - Pastan , et al. August 19, 2
2014-08-19
Immunogenic epitopes of NGEP antigen
Grant 8,748,390 - Schlom , et al. June 10, 2
2014-06-10
Blocking mesothelin peptide fragments
Grant 8,623,828 - Ho , et al. January 7, 2
2014-01-07
Anti-mesothelin antibodies
Grant 8,460,660 - Ho , et al. June 11, 2
2013-06-11
Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
App 20120177567 - WAYNE; Alan S. ;   et al.
2012-07-12
Anti-mesothelin Antibodies
App 20120107933 - Ho; Mitchell ;   et al.
2012-05-03
Immunogenic Epitopes Of Ngep Antigen
App 20120052116 - Schlom; Jeffrey ;   et al.
2012-03-01
Immunogenic peptides for the treatment of prostate and breast cancer
Grant 8,043,623 - Berzofsky , et al. October 25, 2
2011-10-25
Blocking Mesothelin Peptide Fragments
App 20110236385 - Ho; Mitchell ;   et al.
2011-09-29
IRTA2 antibodies and methods of use
Grant 7,999,077 - Pastan , et al. August 16, 2
2011-08-16
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
Grant 7,777,019 - Pastan , et al. August 17, 2
2010-08-17
Anti-mesothelin antibodies having high binding affinity
Grant 7,081,518 - Pastan , et al. July 25, 2
2006-07-25
T-cell receptor.gamma. alternate reading frame protein, (TARP) and uses thereof
Grant 7,052,703 - Pastan , et al. May 30, 2
2006-05-30
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins
Grant 6,423,513 - Fitzgerald , et al. July 23, 2
2002-07-23
Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers
Grant 6,153,430 - Pastan , et al. November 28, 2
2000-11-28
Mesothelium antigen and methods and kits for targeting it
Grant 6,083,502 - Pastan , et al. July 4, 2
2000-07-04
Circularly permuted ligands and circularly permuted chimeric molecules
Grant 6,011,002 - Pastan , et al. January 4, 2
2000-01-04
Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
Grant 5,817,313 - Willingham , et al. October 6, 1
1998-10-06
IL-13 receptor specific chimeric proteins and uses thereof
Grant 5,614,191 - Puri , et al. March 25, 1
1997-03-25
Single chain B3 antibody fusion proteins and their uses
Grant 5,608,039 - Pastan , et al. March 4, 1
1997-03-04
Monoclonal antibody binding cell surface antigens for diagnosing cancer
Grant 5,525,337 - Willingham , et al. June 11, 1
1996-06-11
Monoclonal antibody useful for the diagnosis of cancer
Grant 5,320,956 - Willingham , et al. June 14, 1
1994-06-14
Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors
Grant 5,242,813 - Pastan , et al. September 7, 1
1993-09-07

© 2021 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed